![UNODC World Drug Report 2024](/files/styles/card/public/2024-07/1a.png?h=8606d1af&itok=MnRRWnjp)
![UNODC World Drug Report 2024](/files/styles/card/public/2024-07/1a.png?h=8606d1af&itok=MnRRWnjp)
Despite extensive evidence regarding the negative effects of stigma experienced by people living with HIV (PLHIV) and people who inject drugs within health care settings, comparatively little evidence exists regarding the effectiveness of...
Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
Substance use disorders (SUDs) are highly prevalent and impact individuals' health, well-being, and social functioning. Long-lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and...
Presented by Richard Rawson, PhD, Emeritus Professor in the Department of Psychiatry and Biobehavioral Science, UCLA School of Medicine and a Research Professor at the University of Vermont, this presentation provided an overview of the...
In the magazine CIJ Informa, the participation of CIJ, host chapter institution of ISSUP Mexico, in the 71st Regular Session of CICAD is reviewed.
The Anti-Stigma Network has been launched!
The Anti-Stigma Network has been created by a group of organisations coming together with a shared mission.
Collectively they aim to improve understanding of the stigma and...
Background
Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and...
The crisis of opioid use puts a strain on resources in the United States and worldwide. There are 3 US Food and Drug Administration–approved medications for treatment of opioid use disorder: methadone, buprenorphine...
Question What treatments for cocaine use disorder are associated with objective reductions in cocaine use among adults?
Findings In this meta-analysis of 157 clinical trials comprising 402 treatment groups and 15 842...
Cocaine is an addictive stimulant drug that originates from the leaves of the coca plant, which is indigenous to South America. The drug's effects include heightened alertness, attention, and energy, as well as feelings of euphoria and...
I mercati dell'esaidrocannabinolo (HHC) e dei cannabinoidi semi-sintetici correlati (SSC) sono aree in rapida evoluzione con informazioni relativamente limitate attualmente disponibili.
La situazione europea presentata...
Obiettivo: Comprendere meglio gli attuali sviluppi nel trattamento dell'uso di stimolanti.
Le droghe stimolanti sono seconde solo alla cannabis come classe di droghe illecite più utilizzate a livello globale, rappresentando 68...
L'abuso di sostanze tra i giovani è una delle maggiori preoccupazioni pubbliche nella salute globale. Questo studio si proponeva di esplorare le barriere terapeutiche tra i giovani in Zimbabwe.
I dati sono stati raccolti attraverso...
It has been widely reported that youth alcohol consumption has decreased over recent years. What is the evidence to support this view? What are the implications for alcohol related health harm, promotion of safe drinking and health policy?
...Questo rapporto presenta i dati più recenti e approfonditi sulle morti per overdose e indotte da droghe in Australia, che coprono il periodo dal 2002 al 2021. Si tratta del prodotto più recente di una serie di pubblicazioni annuali sulle...
The Alcohol Use and Mental Health Project ECHO is a no-cost virtual program for health care professionals who are looking for up-to-date and research-based information on working with people who use alcohol.
The program, which is only...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member